JNJ

227.58

+1.12%↑

UNH

366.5

+3.49%↑

TMO

470.15

+0.34%↑

ISRG

466.67

-0.89%↓

ABT

93.81

+1.03%↑

JNJ

227.58

+1.12%↑

UNH

366.5

+3.49%↑

TMO

470.15

+0.34%↑

ISRG

466.67

-0.89%↓

ABT

93.81

+1.03%↑

JNJ

227.58

+1.12%↑

UNH

366.5

+3.49%↑

TMO

470.15

+0.34%↑

ISRG

466.67

-0.89%↓

ABT

93.81

+1.03%↑

JNJ

227.58

+1.12%↑

UNH

366.5

+3.49%↑

TMO

470.15

+0.34%↑

ISRG

466.67

-0.89%↓

ABT

93.81

+1.03%↑

JNJ

227.58

+1.12%↑

UNH

366.5

+3.49%↑

TMO

470.15

+0.34%↑

ISRG

466.67

-0.89%↓

ABT

93.81

+1.03%↑

Search

Quanterix Corp

Fechado

SetorSaúde

3.34 3.41

Visão Geral

Variação de preço das ações

24h

Atual

Mín

3.13

Máximo

3.36

Indicadores-chave

By Trading Economics

Rendimento

10M

-23M

Vendas

3.7M

44M

Margem de lucro

-52.712

Funcionários

450

EBITDA

15M

-17M

Recomendações

By TipRanks

Recomendações

Neutro

Previsão para 12 meses

+64.67% upside

Dividendos

By Dow Jones

Próximos Ganhos

6 de mai. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-141M

155M

Abertura anterior

-0.07

Fecho anterior

3.34

Sentimento de Notícias

By Acuity

50%

50%

177 / 348 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Neutral Evidence

Quanterix Corp Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

28 de abr. de 2026, 23:33 UTC

Ações em Alta

Stocks to Watch: Robinhood, Visa, Seagate Technology, NXP Semiconductors

28 de abr. de 2026, 23:24 UTC

Ganhos

Visa 2Q Revenue Climbs as Consumers Keep Spending; Board Authorizes $20 Billion Buyback -- Update

28 de abr. de 2026, 23:15 UTC

Notícias Principais

U.K. Economy to Suffer Large Loss of Output, Higher Inflation as Result of Middle East Conflict

28 de abr. de 2026, 22:46 UTC

Ganhos

Booking Holdings Cuts Outlook as Middle East Conflict Weighs on Travel Demand -- Update

28 de abr. de 2026, 22:37 UTC

Ganhos

Prudential PLC 1Q New Business Profit $686.0 Million, Up 10% on Year

28 de abr. de 2026, 22:15 UTC

Ganhos
Notícias Principais

Mondelez Reports Developing Market Growth Offsetting U.S., Europe Weakness -- Update

28 de abr. de 2026, 23:33 UTC

Conversa de Mercado
Notícias Principais

Gold Edges Lower on Prospects of Dollar Strength -- Market Talk

28 de abr. de 2026, 23:31 UTC

Ganhos

China Petroleum & Chemical 1Q Net Rose on Higher Crude Oil Prices >0386.HK

28 de abr. de 2026, 23:31 UTC

Ganhos

China Petroleum & Chemical 1Q Capex Was CNY25.17B >0386.HK

28 de abr. de 2026, 23:30 UTC

Ganhos

China Petroleum & Chemical 1Q Net CNY17.74B Vs. Net CNY13.98B >0386.HK

28 de abr. de 2026, 23:30 UTC

Ganhos

China Petroleum & Chemical 1Q Rev CNY706.70B Vs. CNY735.36B >0386.HK

28 de abr. de 2026, 23:19 UTC

Conversa de Mercado
Ganhos

Visa Points to Spending Boost from Tax Refunds in U.S. -- Market Talk

28 de abr. de 2026, 23:09 UTC

Ganhos

Visa 2Q Revenue Climbs as Consumers Keep Spending; Board Authorizes $20B Buyback -- Update

28 de abr. de 2026, 23:03 UTC

Conversa de Mercado

Australia's Inflation Outlook Looks Pretty Grim -- Market Talk

28 de abr. de 2026, 23:01 UTC

Notícias Principais

NIESR Sees One Rate Rise to 4% in Benign Scenario

28 de abr. de 2026, 23:01 UTC

Notícias Principais

NIESR Sees U.K. Economy Growing by Just 0.5% in 'Adverse' Middle East Scenario

28 de abr. de 2026, 23:01 UTC

Notícias Principais

NIESR: BOE's Key Rate Should Rise to 5.25% in Adverse Scenario

28 de abr. de 2026, 23:01 UTC

Notícias Principais

U.K.'s NIESR Lowers 2026 U.K. Economic Growth Forecast to 0.9% From 1.4% in 'Benign' Scenario

28 de abr. de 2026, 23:01 UTC

Notícias Principais

NIESR Sees Inflation Peaking at Over 6% in Adverse Scenario

28 de abr. de 2026, 22:51 UTC

Ganhos

Robinhood Earnings Fall Short. A Crypto Slump Is the Culprit. -- Barrons.com

28 de abr. de 2026, 22:48 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

28 de abr. de 2026, 22:48 UTC

Conversa de Mercado

Australia's 1Q CPI Will Likely Provide Little Relief For RBA -- Market Talk

28 de abr. de 2026, 22:40 UTC

Conversa de Mercado
Notícias Principais

Australian 1Q CPI Will Likely Keep May Hike Alive -- Market Talk

28 de abr. de 2026, 22:32 UTC

Ganhos

Booking Beats on Profit. Travel Demand Outlook Clouded By Iran War. -- Barrons.com

28 de abr. de 2026, 22:25 UTC

Aquisições, Fusões, Aquisições de Empresas

Pernod Ricard and Brown-Forman End Deal Talks -- Update

28 de abr. de 2026, 22:22 UTC

Ganhos

Prudential PLC 1Q New Business Profit $686.0M, Up 10% on Year

28 de abr. de 2026, 22:17 UTC

Conversa de Mercado

Canada Fiscal Update Puts Central Bank on Track to Raise Rates -- Market Talk

28 de abr. de 2026, 22:14 UTC

Ganhos

Prudential PLC 1Q APE Sales Up 6% on Year, to $1.823B >2378.HK

28 de abr. de 2026, 22:14 UTC

Ganhos

Prudential PLC 1Q New Business Profit $686.0M, Up 10% on Year >2378.HK

28 de abr. de 2026, 22:07 UTC

Conversa de Mercado
Notícias Principais

Canada Chamber Frets Over Lost Fiscal Room -- Market Talk

Comparação entre Pares

Variação de preço

Quanterix Corp Previsão

Preço-alvo

By TipRanks

64.67% parte superior

Previsão para 12 meses

Média 5.5 USD  64.67%

Máximo 7 USD

Mínimo 4 USD

Com base em 2 analistas de Wall Street que oferecem metas de preço de 12 meses para Quanterix Corp - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Neutro

2 ratings

0

Comprar

2

Manter

0

Vender

Pontuação Técnica

By Trading Central

5.34 / 6.015Suporte e Resistência

Curto Prazo

Neutral Evidence

Médio Prazo

Bullish Evidence

Longo Prazo

No Evidence

Sentimento

By Acuity

177 / 348 Ranking em Saúde

Sentimento de Notícias

Neutral

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Acima da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Quanterix Corp

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
help-icon Live chat